In Vitro Anticancer and In Silico Studies of Some 1,4‐Benzoxazine‐1,2,4‐oxadiazole Hybrids

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A Mild and Efficient One-Pot Preparation of 1,2,4-Oxadiazoles from Nitriles and Carboxylic Acids Using Vilsmeier Reagent

(2018) Maaroof Zarei   ChemistrySelect

Design, synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity

(2016) Li Zhang et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

One-pot synthesis of fused benzoxazino[1,2,3]triazolyl[4,5-c]quinolinone derivatives and their anticancer activity

(2016) Sirassu Narsimha et al.   RSC Advances

Minimalist Hybrid Ligand/Receptor-Based Pharmacophore Model for CXCR4 Applied to a Small-Library of Marine Natural Products Led to the Identification of Phidianidine A as a New CXCR4 Ligand Exhibiting Antagonist Activity

(2013) Rosa Maria Vitale et al.   ACS Chemical Biology

The ErbB/HER family of protein-tyrosine kinases and cancer

(2013) Robert Roskoski   PHARMACOLOGICAL RESEARCH

Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain

(2012) Jin H. Park et al.   BIOCHEMICAL JOURNAL

Structure and Cytotoxicity of Phidianidines A and B: First Finding of 1,2,4-Oxadiazole System in a Marine Natural Product

(2011) Marianna Carbone et al.   ORGANIC LETTERS

Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus

(2009) Francine Walker et al.   HUMAN PATHOLOGY

Amphiregulin: Role in Mammary Gland Development and Breast Cancer

(2008) Jean McBryan et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA